The Journal‪.‬ The Wall Street Journal

Tesla shareholders voted to reapprove Elon Musk’s multibillion-dollar pay package, signaling support for the EV maker’s CEO and giving the board ammunition in its fight to preserve the court-rejected compensation plan. WSJ’s David Benoit explores the fight to get Musk billions and why the Tesla board is so invested in making the huge pay package happen.



Further Listening: 

- Elon Musk’s Unusual Relationships With Women at SpaceX 

- Why is Tesla Pulling Back on EV Charging? 

- Money, Drugs, Elon Musk and Tesla’s Board 



Further Reading: 

- Tesla Shareholders Vote to Uphold Elon Musk’s $48 Billion Pay Package 

- Elon Musk’s $55.8 Billion Tesla Pay Package Struck Down by Judge 

- Tesla Hits the Road to Persuade Shareholders to Pay Elon Musk $46 Billion 



Learn more about your ad choices. Visit megaphone.fm/adchoices

Joshua Wright was a star in the world of antitrust, from his time at the Federal Trade Commission to his work with some of the biggest tech companies. He was well respected and powerful until accusations of sexual misconduct came to light. WSJ’s Brody Mullins talks us through his reporting on Wright’s downfall.



Further Reading:

- The Hidden Life of Google’s Secret Weapon 

- For Years, an Esteemed Law Professor Seduced Students. Was He Too Important to Fire? 

- Hubris, Revenge and a Breakup Brought Down Big Tech’s Proudest Ally 



Further Listening:

- Elon Musk’s Unusual Relationships With Women at SpaceX 

- Lewd Photos, Booze and Bullying: Inside the FDIC’s Toxic Culture 





Learn more about your ad choices. Visit megaphone.fm/adchoices

The billionaire founder showed several female employees at SpaceX an unusual amount of attention or pursued them. WSJ's Joseph Palazzolo describes the revelations.



Further Reading:

-Elon Musk’s Boundary-Blurring Relationships With Women at SpaceX 



Further Listening:

-Money, Drugs, Elon Musk and Tesla's Board 

-Elon Musk's 'Demon Mode' 

Learn more about your ad choices. Visit megaphone.fm/adchoices

The nation’s first congestion-pricing plan was set to take effect at the end of June. But last week, New York Gov. Kathy Hochul called to indefinitely delay the program. WSJ's Jimmy Vielkind unpacks the surprising move and explores why Hochul made the 11th hour change.



Further Reading:

-New York Gov. Kathy Hochul Abruptly Halts Manhattan Congestion Pricing 



Further Listening:

-NYC’s Food Delivery Workers Fight for a Minimum Wage 

-New York City's 'De Facto Ban' on Airbnb 

Learn more about your ad choices. Visit megaphone.fm/adchoices

The fast-fashion giant hoped to have a splashy U.S. public offering this year. WSJ's Shen Lu explains how the divide between Beijing and Washington got in the way.



Further Reading:

- Shein Promised to Have a Big U.S. IPO. Its China Roots Got in the Way. 

- Fast-Fashion Giant Shein Files to Go Public 



Further Listening:

- Shein Took Over Fast Fashion. Then Came the Backlash. 

- The Mysterious CEO Leading Shein to an IPO 



Learn more about your ad choices. Visit megaphone.fm/adchoices

The rising popularity of GLP-1 drugs could cause all kinds of ripple effects.

According to one estimate, 9% of the U.S. population could be on Ozempic or similar medications by 2030. Meanwhile, drugmakers are already developing the next generation of weight-loss drugs and researchers are studying the possible health benefits beyond weight loss and diabetes, including addiction.

In the final episode of our series we ask: What could all this development mean for businesses, from the food sector to airlines? And who wins and who loses in the post-Ozempic economy?

Guests include: David Ricks, CEO of Eli Lilly; and Mehdi Farokhnia, an addiction researcher at the National Institutes of Health.

Listen to Episodes 1, 2 and 3 of “Trillion Dollar Shot” here. 
Learn more about your ad choices. Visit megaphone.fm/adchoices